Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis

Human Reproduction

Volumn 25, Issue 3, 2010, Pages 734-741

  Lousse, J C ^a   Defrre, S ^a   Colette, S ^a   Van Langendonckt, A ^a   Donnez, J ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Eicosanoid; Leukotriene; Macrophage; Peritoneal endometriosis; Prostaglandin

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; ENZYME; ICOSANOID; MESSENGER RNA; PHOSPHOLIPASE A2 GROUP II; PROSTAGLANDIN E SYNTHASE 1;

ADULT; ARTICLE; CATABOLISM; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENZYMATIC DEGRADATION; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; PERITONEAL ENDOMETRIOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA;

EID: 76749127027     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep408     Document Type: Article

References (52)

1. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1996;67:817-821
2. Banu SK, Lee J, Speights VO, Starzinski-Powitz A, Arosh JA. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 2008; 149:1180-1189.
3. Beck S, Lambeau G, Scholz-Pedretti K, Gelb MH, Janssen MJ, Edwards SH, Wilton DC, Pfeilschifter J, Kaszkin M. Potential of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation. J Biol Chem 2003; 278:29799-29812.
4. Cha YI, DuBois RN. NSAIDs and cancer prevention: targets down-stream of COX-2. Annu Rev Med 2007;58:239-252.
5. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 2002;48:50-56.
6. Chishima F, Hayakawa S, Yamamoto T, Sugitani M, Karasaki-Suzuki M, Sugita K, Nemoto N. Expression of inducible microsomal prostaglandin E synthase in local lesions of endometriosis patients. Am J Reprod Immunol 2007;57:218-226.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
8. Cobellis L, Razzi S, De Simone S, Sartini A, Fava A, Danero S, Gioffrè W, Mazzini M, Petraglia F. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol 2004;116:100-102.
9. De Leon FD, Vijayakumar R, Brown M, Rao CV, Yussman MA, Schultz G. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis. Obstet Gynecol 1986;68:189-194.
10. Dogan E, Sayigili U, Posaci C, Tuna B, Caliskan S, Altunyurt S, Saatli B. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 2004;82:1115-1120.
11. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1686-1690.
12. Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007;88:1505-1533.
13. Ferreira S, Vane J. Half-lives of peptides and amines in the circulation. Nature 1967;215:1237-1240.
14. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-226.
15. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
16. González-Ramos R, Donnez J, Defrère S, Leclercq I, Squifflet J, Lousse JC, Van Langendonckt A. Nuclear factor-kappa B (NF-kB) is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 2007; 13:503-509.
17. Harada R, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril 2001;76:1-10.
18. Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochem Soc Trans 2008;36:543-545.
19. Ishikawa TO, Jain N, Herschman HR. Feedback regulation of cyclooxygenase-2 transcription ex vivo and in vivo. Biochem Biophys Res Commun 2009;378:534-538.
20. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 2007;46:108-125.
21. Koike H, Egawa H, Ohtsuka T, Yamaguchi M, Ikenoue T, Mori N. Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins Leukot Essent Fatty Acids 1992;46:133-137.
22. Koki AT, Khan NK, Woerner BM, Seibert K, Harmon JL, Dannenberg AJ, Soslow RA, Masferrer JL. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot Essent Fatty Acids 2002;66:13-18.
23. Laschke M, Elitzsch A, Scheuer C, Vollmar B, Menger M. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 2007;87:163-171.
24. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004; 122:794-801.
25. Lebovic D, Mueller M, Taylor R. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10.
26. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997;91:197-208.
27. Lindstrom T, Bennett P. Transcriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway. Prostaglandins Leukot Essent Fatty Acids 2004;70:115-135.
28. Lousse JC, Van Langendonckt A, González Ramos R, Defrère S, Renkin E, Donnez J. Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril 2008;90:217-220.
29. Lousse JC, Defrère S, González Ramos R, Van Langendonckt A, Colette S, Donnez J. Involvement of iron, nuclear factor-kappa B (NF-kB) and prostaglandins in the pathogenesis of peritoneal endometriosis-associated inflammation: a review. J Endometr 2009a;1:19-29.
30. Lousse JC, Defrère S, Van Langendonckt A, Gras J, González Ramos R, Colette S, Donnez J. Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid. Fertil Steril 2009b;91: 1668-1675.
31. Matsuzaki S, Canis M, Darcha C, Dallel R, Okamura K, Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 2004;82:1609-1615.
32. Meyer MC, Rastogi P, Beckett CS, McHowat J. Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des 2005; 11:1301-1312.
33. 2-biosynthetic pathway. Prog Lipid Res 2004; 43:3-35.
34. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997;68:585-596. (Pubitemid 27454315)
35. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
36. Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M, Meresman. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 2008;23:2701-2708.
37. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001;16:561-566. (Pubitemid 32218810)
38. Ozawa Y, Murakami T, Tamura M, Terada Y, Yaegashi N, Okamura K. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 2006;86:1146-1151.
39. Peters-Golden M, Henderson W. Leukotrienes. New Engl J Med 2007; 357:1841-1854.
40. Rizzo MT, Nguyen E, Aldo-Benson M, Lambeau G. Secreted phospholipase A(2) induces vascular endothelial cell migration. Blood 2000;96:3809-3815.
41. Sales K, Jabbour H. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003;126:559-567. (Pubitemid 37540615)
42. Sano M, Morishita T, Nozaki M, Yokoyama M, Watanabe Y, Nakano H. Elevation of the phospholipase A2 activity in peritoneal fluid cells from women with endometriosis. Fertil Steril 1994;61:657-662.
43. Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res 2009;50:S423-S428.
44. Tai HH, Tong M, Ding Y. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer. Prostaglandins Other Lipid Mediat 2007; 83:203-208.
45. 2. Biochim Biophys Acta 2006;1761:1289-1300. (Pubitemid 44738703)
46. Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008;22:275-306.
47. Wakimoto N, Wolf I, Yin D, O'Kelly J, Akagi T, Abramovitz L, Black KL, Tai HH, Koeffler HP. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Cancer Res 2008; 68:6978-6986.
48. Welsh TN, Hubbard S, Mitchell CM, Mesiano S, Zarzycki PK, Zakar T. Optimization of a solid phase extraction procedure for prostaglandin E2, F2 alpha and their tissue metabolites. Prostaglandins Other Lipid Mediat 2007;83:304-310.
49. Willman EA, Collins WP, Clayton SG. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol 1976;83:337-341.
50. Wu MH, Sun HS, Lin CC, Hsiao KY, Chuang PC, Pan HA, Tsai SJ. Distinct mechanisms regulate cyclooxygenase-1 and-2 in peritoneal macrophages of women with and without endometriosis. Mol Hum Reprod 2002;8:1103-1110.
51. Wu M, Shoji Y, Chuang P, Tsai S. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 2007;9:1-20.
52. Yamaguchi M, Mori N. Prostaglandin and leukotriene concentration of the peritoneal fluid of endometriosis and other gynecologic disorders in the secretory phase. Prostaglandins Leukot Essent Fatty Acids 1990;39:43-45.